Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Phenofibrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

99 API Suppliers, 26 USDMF, 16 CEP/COS, 3 JDMF, 15 EU WC, 29 KDMF, 17 NDC API, 49 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

300 FDF Dossiers, 131 FDA Orange Book, 52 Europe, 12 Canada, 34 Australia, 3 South Africa, 68 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 160MG, CAPSULE;ORAL - 150MG, CAPSULE;ORAL - 50MG, TABLET;ORAL - 145MG, TABLET;ORAL - 48MG, CAPSULE;ORAL - 130MG, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 43MG, CAPSULE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 105MG, TABLET;ORAL - 35MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 20 SPI Pharma, 14 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Kewpie Corporation, 14 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Finar, 14 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 15 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 52 Thickeners and Stabilizers, 52 Solubilizers, 48 Disintegrants & Superdisintegrants, 44 Direct Compression, 35 Controlled & Modified Release, 35 Granulation, 32 Taste Masking, 29 Topical, 25 Lubricants & Glidants, 23 Film Formers & Plasticizers, 22 Parenteral, 21 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 17 Emulsifying Agents, 10 Rheology Modifiers, 10 API Stability Enhancers, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 61 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 59 Regulatory FDF Prices

MARKET PLACE

25 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

20 US Patents, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 5 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	IOL Chemicals and Pharmaceuticals	India	M/s IOL Chemicals and Pharmaceuticals Ltd	WC-0004	Fenofibrate IP/BP/USP/Ph. Eur.	2025-02-27	2028-03-17	Village Fatehgarh Channa Mansa Road (Trident Complex), Barnala, District Barnala -148101, Punjab (India)
04/06/2025	Aalidhra Pharmachem	India	M/s Aalidhra Pharmachem Pvt Ltd	WC-0425	Fenofibrate IP/EP/USP	2022-11-02	2025-11-01	Plot No. 163&164, G.I.D.C, Nandesari, Dist-Vadodara -391-340, Gujarat, India

Phenofibrate

Phenofibrate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

99 API Suppliers

26 USDMF

16 CEP/COS

3 JDMF

15 EU WC

29 KDMF

17 NDC API

49 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

300 FDF Dossiers

131 FDA Orange Book

52 Europe

12 Canada

34 Australia

3 South Africa

68 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 160MG

CAPSULE;ORAL - 150MG

CAPSULE;ORAL - 50MG

TABLET;ORAL - 145MG

TABLET;ORAL - 48MG

CAPSULE;ORAL - 130MG

CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 43MG

CAPSULE;ORAL - 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 105MG

TABLET;ORAL - 35MG

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Evonik

3 Rochem International Inc

20 SPI Pharma

14 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

8 Faran Shimi Pharmaceutical

8 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

2 Kewpie Corporation

14 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 ACG Worldwide

7 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

35 BASF

1 Bioplus Life Sciences

2 Clariant

14 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

2 Finar

14 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

3 Nanjing Bold Chemical

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

8 Pluviaendo

CAPSULE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 90MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons